Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Mitazalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody |
Mitazalimab |
vanalimab |
CD40 |
Whole mAb |
||
Pre-Made Modakafusp biosimilar, Whole mAb Fusion: Anti-ADPRC therapeutic antibody |
Modakafusp |
NA |
ADPRC |
Whole mAb Fusion |
||
Pre-Made Modotuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Modotuximab |
Zatuximab |
EGFR |
Whole mAb |
||
Pre-Made Mogamulizumab biosimilar, Whole mAb, Anti-CCR4 Antibody: Anti-CKR4/K5-5/CD194/CMKBR4/ChemR13/CC-CKR-4/HGCN:14099 therapeutic antibody |
Mogamulizumab |
NA |
CCR4 |
Whole mAb |
||
Pre-Made Monalizumab biosimilar, Whole mAb, Anti-KLRC1/NKG2A Antibody: Anti-CD159A/NKG2 therapeutic antibody |
Monalizumab |
NA |
KLRC1 |
Whole mAb |
||
Pre-Made Mosunetuzumab biosimilar, Bispecific mAb, Anti-CD3E;MS4A1/CD20 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Mosunetuzumab |
NA |
CD3E,MS4A1 |
Bispecific mAb |
||
Pre-Made Motavizumab biosimilar, Whole Mab: Anti-RSV gpF therapeutic antibody |
Motavizumab |
NA |
RSV gpF |
Whole mAb |
||
Pre-Made Moxetumomab biosimilar, Fv Fusion, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody |
Moxetumomab |
NA |
CD22 |
Fv Fusion |
||
Pre-Made Murlentamab biosimilar, Whole mAb, Anti-AMHR2 Antibody: Anti-AMHR/MISR2/MISRII/MRII therapeutic antibody |
Murlentamab |
NA |
AMHR2 |
Whole mAb |
||
Pre-Made Muromonab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Muromonab |
NA |
CD3E |
Whole mAb |
||
Pre-Made Nadecnemab biosimilar, Whole mAb, Anti-GFRA3 Antibody: Anti-GDNFR3 therapeutic antibody |
Nadecnemab |
NA |
GFRA3 |
Whole mAb |
||
Pre-Made Namilumab biosimilar, Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF therapeutic antibody |
Namilumab |
NA |
CSF2 |
Whole mAb |
||
Pre-Made Naptumomab biosimilar, Fab Fusion, Anti-TPBG Antibody: Anti-5T4/M6P1/5T4AG/WAIF1 therapeutic antibody |
Naptumomab |
NA |
TPBG |
Fab Fusion |
||
Pre-Made Naratuximab biosimilar, Whole mAb ADC, Anti-CD37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody |
Naratuximab |
NA |
CD37 |
Whole mAb ADC |
||
Pre-Made Narnatumab biosimilar, Whole mAb, Anti-MST1R/RON Antibody: Anti-RON/SEA/PTK8/CD136/NPCA3/CDw136 therapeutic antibody |
Narnatumab |
NA |
MST1R |
Whole mAb |
||
Pre-Made Narsoplimab biosimilar, Whole mAb, Anti-MASP2 Antibody: Anti-MAP-2/MAP19/MASP-2/MASP1P1/sMAP therapeutic antibody |
Narsoplimab |
NA |
MASP2 |
Whole mAb |
||
Pre-Made Natalizumab biosimilar, Whole mAb, Anti-ITGA4 Antibody: Anti-CD49D/IA4 therapeutic antibody |
Natalizumab |
NA |
ITGA4 |
Whole mAb |
||
Pre-Made Navivumab biosimilar, Whole Mab: Anti-Influenza A HA therapeutic antibody |
Navivumab |
NA |
Influenza A HA |
Whole mAb |
||
Pre-Made Navicixizumab biosimilar, Bispecific mAb, Anti-DLL4;VEGFA Antibody: Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1 therapeutic antibody |
Navicixizumab |
NA |
DLL4,VEGFA |
Bispecific mAb |
||
Pre-Made Naxitamab biosimilar, Whole Mab: Anti-Ganglioside GD2 therapeutic antibody |
Naxitamab |
NA |
Ganglioside GD2 |
Whole mAb |
||
Pre-Made Necitumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Necitumumab |
NA |
EGFR |
Whole mAb |
||
Pre-Made Nemolizumab biosimilar, Whole mAb, Anti-IL31RA/IL31R Antibody: Anti-CRL/CRL3/GLM-R/GLMR/GPL/IL-31RA/PLCA2/PRO21384/hGLM-R/zcytoR17 therapeutic antibody |
Nemolizumab |
NA |
IL31RA |
Whole mAb |
||
Pre-Made Nesvacumab biosimilar, Whole mAb, Anti-ANGPT2 Antibody: Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody |
Nesvacumab |
NA |
ANGPT2 |
Whole mAb |
||
Pre-Made Netakimab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody |
Netakimab |
NA |
IL17A |
Whole mAb |
||
Pre-Made Nidanilimab biosimilar, Whole mAb, Anti-IL1RAP Antibody: Anti-C3orf13/IL-1RAcP/IL1R3 therapeutic antibody |
Nidanilimab |
nadunolimab |
IL1RAP |
Whole mAb |
||
Pre-Made Nimacimab biosimilar, Whole mAb, Anti-CNR1/CB1 Antibody: Anti-CANN6/CB-R therapeutic antibody |
Nimacimab |
NA |
CNR1 |
Whole mAb |
||
Pre-Made Nimotuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Nimotuzumab |
NA |
EGFR |
Whole mAb |
||
Pre-Made Nipocalimab biosimilar, Whole mAb, Anti-FCGRT Antibody: Anti-FCRN/FcgammaRn/alpha-chain therapeutic antibody |
Nipocalimab |
NA |
FCGRT |
Whole mAb |
||
Pre-Made Nirsevimab biosimilar, Whole Mab: Anti-RSV therapeutic antibody |
Nirsevimab |
NA |
RSV |
Whole mAb |
||
Pre-Made Nivatrotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-GD2;CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Nivatrotamab |
NA |
GD2,CD3E |
Bispecific Mixed mAb and scFv |
||
Pre-Made Nivolumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Nivolumab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Nurulimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody |
Nurulimab |
NA |
CTLA4 |
Whole mAb |
||
Pre-Made Obexelimab biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Obexelimab |
NA |
CD19 |
Whole mAb |
||
Pre-Made Obiltoxaximab biosimilar, Whole Mab: Anti-Anthrax Protective Antigen therapeutic antibody |
Obiltoxaximab |
NA |
Anthrax Protective Antigen |
Whole mAb |
||
Pre-Made Obinutuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Obinutuzumab |
Afutuzumab |
MS4A1 |
Whole mAb |
||
Pre-Made Obrindatamab biosimilar, Bispecific scFv with Domain Crossover, Anti-CD276;CD3E Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2;T3E/TCRE/IMD18 therapeutic antibody |
Obrindatamab |
NA |
CD276,CD3E |
Bispecific scFv with Domain Crossover |
||
Pre-Made Ocaratuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ocaratuzumab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Ociperlimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody |
Ociperlimab |
NA |
TIGIT |
Whole mAb |
||
Pre-Made Ocrelizumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ocrelizumab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Odesivimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody |
Odesivimab |
NA |
Zaire Ebolavirus GP |
Whole mAb |
||
Pre-Made Odronextamab biosimilar, Bispecific mAb, Anti-MS4A1/CD20;CD3E Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18 therapeutic antibody |
Odronextamab |
NA |
MS4A1,CD3E |
Bispecific mAb |
||
Pre-Made Ofatumumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ofatumumab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Olaratumab biosimilar, Whole mAb, Anti-PDGFRA Antibody: Anti-CD140A/PDGFR-2/PDGFR2 therapeutic antibody |
Olaratumab |
NA |
PDGFRA |
Whole mAb |
||
Pre-Made Oleclumab biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody: Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic antibody |
Oleclumab |
NA |
NT5E |
Whole mAb |
||
Pre-Made Olendalizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody |
Olendalizumab |
lendalizumab |
C5 |
Whole mAb |
||
Pre-Made Olinvacimab biosimilar, Whole mAb, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody |
Olinvacimab |
Tanibirumab |
KDR |
Whole mAb |
||
Pre-Made Olokizumab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody |
Olokizumab |
NA |
IL6 |
Whole mAb |
||
Pre-Made Omalizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody |
Omalizumab |
NA |
IGHE |
Whole mAb |
||
Pre-Made Omburtamab biosimilar, Whole mAb Radiolabelled, Anti-CD276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody |
Omburtamab |
NA |
CD276 |
Whole mAb Radiolabelled |
||
Pre-Made Omodenbamab biosimilar, Whole Mab: Anti-SpA therapeutic antibody |
Omodenbamab |
NA |
SpA |
Whole mAb |
